With a greater understanding of IIH, tailored treatment options arise. Medication used to treat glaucoma, epilepsy, altitude sickness, periodic paralysis, idiopathic intracranial hypertension, urine alkalinization, and heart failure. Click the term to read more is a first-line medication that can decrease the amount of Fluid that is made by specialized cells in the ventricles of the brain. Click the term to read more (Fluid that is made by specialized cells in the ventricles of the brain. Click the term to read more)) production, thereby decreasing intracranial pressure, but is not a curative therapy. A medication used to manage and treat glaucoma, idiopathic intracranial hypertension, altitude sickness, congestive heart failure, and epilepsy, among other diseases. Click the term to read more and other classes of medications decrease production of CSF or help eliminate extra fluid from the body in an effort to decrease intracranial pressure. Unfortunately, these medications can only maintain patients in remission of this syndrome. Once a patient is taken off this therapy, symptoms return in most cases. For patients who fail therapy with acetazolamide or who cannot tolerate the medication, other treatment options exist.
Treatment options for IIH include surgery, including the placement of a A hollow tube that can be surgically placed in the sinus to help drain cerebrospinal fluid. Click the term to read more to drain fluids, and A minimally invasive surgery during which a metallic mesh in the shape of a tube (stent) is placed in the sinus. Click the term to read more. These interventions each have their own risks and benefits and should be a part of your discussion with your treating physician.
- Wall A, Lee A. Idiopathic intracranial hypertension (pseudotumor cerebri): Prognosis and treatment. UpToDate. Reviewed September 21, 2021. Accessed May 12, 2022. https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-prognosis-and-treatment